(PRWEB) April 28, 2013
Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] – Forecasts to 2017” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, APAC, and Rest of the World.
Early buyers will receive 10% customization on reports.
This report studies the global neuromodulation devices market (2012 to 2017).
The global neuromodulation market has been broadly divided into two major segments based on the nature of procedure, namely, invasive or internal neuromodulation and non-invasive or external neuromodulation.
The invasive neuromodulation segment comprises of spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation and gastric nerve stimulation, whereas the non-invasive technology segment consists of transcranial magnetic stimulation (TMS) and transcutaneous electrical neuromodulation (TENS). All the techniques are further sub-segmented by its various applications.
The neuromodulation market is expected to be a high growth market in the coming decade. It consists of devices used to modulate or alter neurons by means of passing electric pulses through the nerves. Notable segments of the neuromodulation market are spinal cord stimulation, deep brain stimulation, and vagus nerve stimulation.
Vagus nerve stimulation, being nascent in the market, will represent the maximum growth in the coming years fuelled by its wider scope of application and less invasive nature as compared to other SCS or DBS techniques. The spinal cord stimulation technique holds maximum share in the market, yet, it is observed to have a slower growth.
Research studies and clinical trials also show a promising future for DBS and transcranial magnetic stimulation market in new applications like Alzheimer’s, drug resistant depression, tinnitus, etc.
The key factors that drive the neuromodulation market are higher incidences of endemic diseases, rise in aging population, technological advancement, devices under approval, and presence of several niche players. Reimbursement in certain geographies and cost of devices are major challenges faced by this market.
North America is estimated to account for the maximum share of the neuromodulation market in 2012, followed by Europe, and Asia-Pacific countries like Japan, India, and China.
Buy a copy of this report at http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=921.
Find related Reports to - Medical Devices Market
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Connect with us on LinkedIn
Connect with us on Facebook